Pharmacovigilance is the practice of monitoring the safety and effectiveness of pharmaceutical drugs after they have been released to the market. At JAWA Group, our pharmacovigilance team works diligently to ensure patient safety by identifying, assessing, and managing adverse drug reactions (ADRs) and other drug-related issues. We collaborate closely with healthcare professionals and regulatory authorities, to collect, process and analyze data on the safety of our products. Our commitment to pharmacovigilance allows us to continuously improve drug safety profiles, enhance public health, and ensure that patients benefit from the highest standards of care throughout the product lifecycle.